APRE AGENCY FOR THE PROMOTION OF EU RESEARCH

Transcription

1 APRE AGENCY FOR THE PROMOTION OF EU RESEARCH FP7 PEOPLE PROGRAMME University L. Bocconi, May 2012 Katia Insogna FP7 National Expert/NCP People & Regional

2 How to write a successful proposals in individual driven MCA : call for proposal IEF 2012

3 Publication of call 13 March 2012 Deadline for submission of proposals 16 August 2012 at Brussels local time Evaluation of proposals October 2012 Evaluation Summary Reports sent to proposal coordinators (initial information letter) Invitation letter to successful coordinators to launch grant agreement negotiationswith the REA services [Indicative Timetable] End of November 2012 December 2012 Letter to unsuccessful applicants From December 2012 Signature of first grant agreements From March 2013

4 - Proposals must be submitted electronically using the Electronic Proposal Submission Service (EPSS) - They are received by the REA before the deadline Call deadlines are absolutely final and are strictly enforced Once the deadline has passed the REA can accept no further additions, corrections or resubmissions

5 Career Restart Panel: exception to the rule for mobility Researchers must not have resided or carried out their main activity in the country of their host organisation for more than 3 years in the 5 years immediately prior to the relevant deadline for submission of proposals. In addition, they must not have been active in research for at least 12 months immediately prior to the deadline for submission of proposals. [Eligibility]

6 Call published on the Research Participant Portal Publication of FP7 calls officially switched from CORDIS to the Research Participant Portal.

7 [Come registrarsi]

8 Documentation Call for proposal Work programme Guide for applicant (Call-Specific) (Common) (Ethics Parts) ESSENTIAL!! Rules for the participation Financial Guidelines

9 [Submission]

10 before the call deadline, the researcher would be considered as the "proposal coordinator". However after the call deadline the scientist in charge will be the only single contact point. The researcher and the scientist in charge cannot be the same person. [Submission]

11 [Registration]

12 [Registration]

13 [Come registrarsi]

14 [Come registrarsi]

15 A1: A2: A3: A4: Information on the Proposal Information on the Host organisation Information on the Researcher Funding Request [PART A: administrative forms]

16 [EPSS]

17 [EPSS: Part A]

18 Proposal Acronym &Title Evaluation Panel Total Duration in months Call identifier Keywords abstract max 2000 characters Similar proposals Ethics Issues [A1]

19 Organisation legal name: es. University, not Dep.t Status of Legal entity [A2]

20 Scientist in charge Authorised person to sign the grant agreement with the REA [A2]

21 Nationality Place of activity/place of residence (previous 5 years) Per eleggibilità Full-time postgraduate research experience [A3]

22 Financial Regime For the researcher

23 Per year Employment / full social security A Minimum social security (stipend) B Experienced 4-10 yrs Experienced > 10 yrs Monthly amount *It is then adjusted, applying a correction factor for the cost of living according to the country (IT: 106.6) [LIVING ALLOWANCE]

24 Allowances: mobility, travel and career exploratory allowance have been merged into one single allowance. This mobility allowance is a monthly payment of a flat rate contribution to cover expenses related to the mobility (relocation, family expenses,language courses, travel expenses etc.) Depending on the family situation : 1000/month: experienced researcher with family obligations 700/month: experienced researcher without family obligations [News]

25 Financial Regime for the host organisation

26 A contribution to the training expenses of the eligible experienced researcher managed by the host organisation Es: consumables, conferences/trainings, memberships journals, other fees, etc 800 per researcher-month Overheads* Fixed-amount of 700 per researcher-month * the correction factor for the cost of living ** No Management from 2012 call [for the Host organisation]

27 An experienced researcher with 8 years of experience and with family charges, coming from Bucharest to Paris for 2 years with an Intra-European Fellowship under an employment contract: Living allowance: 58,500 x 2 years = 117,000 Mobility allowance: 1000 x 24 months = 24,000 Correction factor for France =115.8% (Living allowance + Mobility allowance)* Correction factor for France = 141,000 x 115.8% = 163,278 European Union Contribution for the experienced researcher (gross): 163,278 [Example]

28 Contribution to the participation expenses of eligible experienced researchers (managed by the host organisation) Training, research and dissemination costs: 800 x 24 = 19,200 European Union Contribution for the activities carried out by the experienced researcher: 182,478 EXPENSES FOR THE ACTIVITIES CARRIED OUT BY THE HOST ORGANISATION FOR THE BENEFIT OF THE EXPERIENCED RESEARCHER ARE ADDED TO THIS AMOUNT: Management costs and contribution to overheads: 700 x 24 = 16,800 Correction factor for France = 115.8% (Total management costs and contribution to overheads) x Correction factor for France = 16,800 x 115.8% = 19,454.4 [Example]

29 In summary: Contribution Budget ( ) Contribution for the benefit of the experienced researcher 182,478 Management costs and contribution to overheads 19,454.4 Total Maximum EU contribution 201,932.4 [Example]

30 Year of the project Type of contract Mobility allowance [A4]

31 Instructions for drafting "Part B" of the Proposal You must use exclusively PDF. Uploading in EPSS B1 S&T Quality B2 Training B3 Researcher B4 Implementation B5 Impact B6 Ethical issues The maximum length of part B is 27 pages (excluding table of contents; the ethics issues section as well as start and end pages) [PART B]

32 [EPSS]

33 [EPSS]

34 Scientific and technological quality, including any interdisciplinary and multidisciplinary aspects of the proposal (State of Art: EU Polic and research field; objectives; results) Research methodology (also refer to B2 and B4) Originality and innovative nature of the project Timeliness and relevance of the project (why now??) Host scientific expertise in the field (excellence!no web site info!) Quality of the group / supervisors (list publications, international collaborations, others..) [B1: S&T Quality] <8 pages

35 Clarity and quality of the research training objectives for the researcher (use tables/gannt schemes! Need for Personal Career Development Plan. Be precise with foressen seminars/wks: where, when, outocomes) Relevance and quality of additional scientific training as well as of complementary skills offered (IPR; Project management, languages, teaching, others) Host expertise in training experienced researchers in the field and capacity to provide mentoring/ tutoring [B2: TRAINING] <2 pages

36 Research experience (EUROPASS CV!!!!) Research results (incl. Patents, publications, teaching, etc, taking into account the level of experience) Independent thinking and leadership qualities Match between the fellow s profile and project (can you do it? too ambitious?) Potential for reaching a position of professional maturity Potential to acquire new knowledge [B3: RESEARCHER CV] <7 pages

37 Quality of infrastructures / facilities and international collaborations of the host (what you will be using?) Practical arrangements for the implementation and management of the scientific project (who will manage and monitor your project and how?) Feasibility and credibility of the project, incl. work plan (Work plan: table with activities divided per periods of grant. Need for Personal Career Development Plan; IPR) Practical and administrative arrangements and support for the hosting of the fellow (documents, Visa, employment contract, language schools, accommodation, others) [B4: IMPLEMENTATION] <6 pag.

38 Potential of acquiring competencies during the fellowship to improve the prospects of reaching and/or reinforcing a position of professional maturity, diversity and independence, in particular through exposure to complementary skills training Contribution to career development or re-establishment where relevant Contribution to European excellence and European competitiveness Benefits to ERA Impact on proposed outreach activities (dissemination activites directed to general public to create awareness, such as: summer schools, wkshops, multimedia, E-newsletter) [B5: IMPACT] <4 pag.

39 Describe any ethical issues Special issues: Informed consent Data protection issues Use of animals Human embryonic stem cells No page limit [B6: ETHICAL ISSUES]

40

41 [EPSS]

42 Referee name Referee [EPSS]

43 Up to three referees can be nominated to provide assessments of the experienced researcher Referees' assessments cannot be submitted after the call closure If you nominate referees close to the call deadline then this leaves them very little time to submit their assessments [REFEREES]

44 [Check Validation]

45 [Check Validation]

46 CRITERIA thresold weithting S&T Quality 3/5 25% Training 3/5 15% Researcher 4/5 25% Implementation N/A 15% Impact 3.5/5 20% 70/100% [Criteria of evaluation]

47 Valutazione tutte le azioni Eleven centres and research groups active in andrology and medical sexology have been selected: Leuven (B), Muenster (D), Leipzig (D), Barcelona (E), Rome (I), Florence (I) (these biomedical centres also have interdisciplinary connections with psychological and psychosexological research groups and inter sectorial connections with research groups in the sectors of sociology and science of communication; complementary training described in point B2.1 will be organised in these Centres); Malmoe (S), Manchester (UK), Giessen (D), Tartu (EE), Lodz (PL) (centres with clinical and bio-molecular facilities). See also point B3 with the individual Centres description. As previously noted, these centres are already linked by a common training project under the EAA. This new research and training project will be able to make use of an already effective network. Also inserted in the Network will be the companies most involved in producing the latest generation products active in the andrological field: Serono, Organon, Ferring, Sigma Tau producing hormones and drugs proposed for therapy male infertility, Eli Lilly, Pfizer, Bayer, and GSK, manufacturers of various type 5 phosphodiesterase inhibitors acting on erectile dysfunction, Johnson & Johnson, manufacturer of the forthcoming selective inhibitor of the serotonin reuptake, specifically aimed at treating premature ejaculation, Schering and Solvay, manufacturers of new testosterone formulations with innovative, specific administration methods dedicated to age-related forms of hypogonadism. Part of the complementary training describe in point B2.1 will be organised by experts from these pharmaceutical companies. List of involved Centres Malmö (S), University of Lund, Department of Urology Malmö, Chairman Prof. Aleksander Giwercman Manchester (UK), Department of Endocrinology, Manchester Royal Infirmary, Chairman Prof. Frederick Wu Tartu (EE), Department of Urology, Tartu University Hospital, Chairman Prof. Margus Punab Leuven (B), Department of Endocrinology, University Hospital, Chairman Prof. Dirk Vanderschueren Muenster (D), Institute of Reproductive Medicine University of Munster, Chairman Prof. Eberhard Nieschlag Giessen (D), Department of Dermatology, Justus-Liebig University of Giessen, Chairman Prof. Andreas Meinhardt Leipzig (D), Department of Andrology and Dermatology, University of Leipzig, Hans-Juergen Glander Lodz (PL), Department of Andrology and Reproductive Endocrinology, Medical University of Lodz, Chairman Prof. Krzysztof Kula Barcelona (E), Fundacion Puigvert Andrology Service, Clinica de la Santa Creu, Chairman Prof. Osvaldo Rajmil Rome (I), Department of Medical Physiopathology, University of Rome La Sapienza, Co-Chairmen Prof. Andrea Lenzi and Prof. Franco Dondero [Suggestions]

48 Valutazione tutte le azioni A B C D E F [Suggestions]

49 Valutazione tutte le azioni [Suggestions]

50 THANKS FOR YOUR ATTENTION! APRE Agenzia per la Promozione della Ricerca europea via Cavour, Roma insogna@apre.it Tel. (+39) Fax. (+39) Katia Insogna insogna@apre.it Angelo D Agostino dagostino@apre.it